id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-0564-0006,FDA,FDA-1998-N-0564,Biotechnology Industry Organization - Extension of Comment Period Request,Other,EXT-Request for Extension Comment Due Date,2009-06-08T04:00:00Z,2009,6,2009-06-08T04:00:00Z,,2013-08-11T04:19:39Z,,0,0,090000648059b788
FDA-1998-N-0564-0007,FDA,FDA-1998-N-0564,HF-22 to Biotechnology Industry Organ. - Letter,Other,ANS-Answer,2009-06-08T04:00:00Z,2009,6,2009-06-08T04:00:00Z,,2013-08-11T04:19:39Z,,0,0,090000648059b789
FDA-1998-N-0564-0008,FDA,FDA-1998-N-0564,Procter and Gamble - Comment,Other,CP-Citizen Petition,2009-06-08T04:00:00Z,2009,6,2009-06-08T04:00:00Z,,2013-07-27T21:45:47Z,,0,0,090000648059b78a
FDA-1998-N-0564-0002,FDA,FDA-1998-N-0564,"Transcript of July 8, 1998 meeting",Other,TR-Transcript,2009-06-05T04:00:00Z,2009,6,2009-06-05T04:00:00Z,,2009-06-05T16:14:35Z,,0,0,090000648059b78b
FDA-1998-N-0564-0001,FDA,FDA-1998-N-0564,"Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Bioiogics, and Devices",Proposed Rule,NPR-Notice of Proposed Rule-Making,2009-05-29T04:00:00Z,2009,5,2009-05-29T04:00:00Z,1998-07-24T03:59:59Z,2009-05-29T15:40:52Z,,0,0,090000648059b782